Bharat Biotech's Covaxin 81 pc efficient in Phase 3 trials

| | New Delhi
  • 0

Bharat Biotech's Covaxin 81 pc efficient in Phase 3 trials

Wednesday, 03 March 2021 | PTI | New Delhi

Bharat Biotech's Covaxin 81 pc efficient in Phase 3 trials

Vaccine major Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials.

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research, the Hyderabad-based company said in a statement.

"Today is an important milestone in vaccine discovery, for science and our fight against coronavirus. With today's results from our Phase 3 clinical trials, we have now reported data on our COVID-19 vaccine from Phase 1, 2, and 3 trials involving around 27,000 participants," Bharat Biotech Chairman and Managing Director Krishna Ella said.

Covaxin demonstrates high clinical efficacy trend against COVID-19 but also significant immunogenicity against the rapidly emerging variants, he added.

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Covaxin and Oxford-AstraZeneca's Covishield are the two vaccines that are being administered in the country.

State Editions

700-gram baby gets new life in city hosp

28 September 2022 | PNS | Bhubaneswar

Sahoo’s smart watch, CCTV disk sent for test

28 September 2022 | PNS | Bhubaneswar

More thundershowers to lash State

28 September 2022 | PNS | Bhubaneswar

CM in B’luru; Investors’ Meet today

28 September 2022 | PNS | Bhubaneswar

Shreemandir land records to be digitised

28 September 2022 | PNS | Bhubaneswar

BBSR-Tirupati train from Oct 1

28 September 2022 | PNS | Bhubaneswar

Sunday Edition

Time to tame the rabble rousers

25 September 2022 | Navin Upadhyay | Agenda

Decode ‘those’ genes

25 September 2022 | HEALTH PIONEER | Agenda

COVID-19 Pandemic: The Battles India Won

25 September 2022 | Prof (Dr) Balram Bhargava | Agenda

NEWS BRIEF

25 September 2022 | HEALTH PIONEER | Agenda

Tobacco ads: Celebrities shirk moral responsibility

25 September 2022 | Nibedita Priyadarshini Jena | Agenda

Address fault lines, Raja yoga will bear fruit

25 September 2022 | Bharat Bhushan Padmadeo | Agenda